O atual e preocupante perfil epidemiológico da coqueluche no Brasil - The current and worrisome epidemiology of pertussis in Brazil

Abstract

Objective: To analyze the prevalence of pertussis (whooping cough) in Brazil between 2000 and 2014, and the mortality rate between 2000 and 2013, correlating with the distribution by sex and age group. Methods: Analytical ecological study with temporal design. For data collection, were used as sources SIH, SIM, SINAN and IBGE. The variables analyzed were gender and age. Results: There was a great increase in whooping cough prevalence in Brazil. In 2000, the prevalence in 100.000 inhabitants was 0.5 (95% CI: 0.48 -0.54), jumping in 2014, to 2.43 (95% CI: 2.36 -2.50). Children under one year are the most affected. Both sexes presented a higher prevalence rate in 2014, when male sex reached a rate of 2.3 (95% CI: 2.21 -2.4) and, the female, 2.55 for every 100,000 (95% CI: 2.46 -2.65). The mortality rate for whooping cough increased during the study period. In 2000, the rate was 0.53 per 100.000 inhabitants (95% CI: 0.23 -1.24), reaching the minimum in 2006, with a value of 0.1 (95% CI: 0.2 -0.55). The mortality from the disease reached the higher value in the following year, in 2007, with a rate of 13.46 (95% CI: 11.41 -15.87). Conclusions:The panorama of whooping cough in Brazil has been unfavorable in the last years, since the prevalence and the mortality increased considerably in the period of time studied. Children younger than 1 year are the most affected by the disease, which does not show a significant predilection when it comes to sex.

Coqueluche No Amazonas: Uma Série Histórica De Dez Anos

“…Geralmente, crianças maiores ou adultos introduzem a doença na família e podem manifestar um quadro clínico clássico ou formas O critério clínico é considerado para indivíduos menores de 6 meses que, independentemente do estado vacinal, apresentem tosse há dez dias ou mais associada a dois ou mais dos sintomas a seguir: tosse paroxística, estritor inspiratório, vômito após tossir, cianose, apneia e engasgo. Para os demais indivíduos, considera-se, independentemente do estado vacinal, apresenta tosse, com duração de 14 dias ou mais associada a dois ou mais dos sintomas a seguir: tosse paroxística, guincho inspiratório, vômito após tosse 8 .…”